1. Home
  2. ATNM vs BDL Comparison

ATNM vs BDL Comparison

Compare ATNM & BDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATNM
  • BDL
  • Stock Information
  • Founded
  • ATNM 2000
  • BDL 1959
  • Country
  • ATNM United States
  • BDL United States
  • Employees
  • ATNM N/A
  • BDL N/A
  • Industry
  • ATNM Biotechnology: Pharmaceutical Preparations
  • BDL Restaurants
  • Sector
  • ATNM Health Care
  • BDL Consumer Discretionary
  • Exchange
  • ATNM Nasdaq
  • BDL Nasdaq
  • Market Cap
  • ATNM 46.5M
  • BDL 48.0M
  • IPO Year
  • ATNM N/A
  • BDL N/A
  • Fundamental
  • Price
  • ATNM $1.21
  • BDL N/A
  • Analyst Decision
  • ATNM Strong Buy
  • BDL
  • Analyst Count
  • ATNM 4
  • BDL 0
  • Target Price
  • ATNM $8.75
  • BDL N/A
  • AVG Volume (30 Days)
  • ATNM 1.4M
  • BDL 1.8K
  • Earning Date
  • ATNM 04-29-2025
  • BDL 05-13-2025
  • Dividend Yield
  • ATNM N/A
  • BDL 2.13%
  • EPS Growth
  • ATNM N/A
  • BDL N/A
  • EPS
  • ATNM N/A
  • BDL 1.78
  • Revenue
  • ATNM N/A
  • BDL $193,230,000.00
  • Revenue This Year
  • ATNM N/A
  • BDL N/A
  • Revenue Next Year
  • ATNM N/A
  • BDL N/A
  • P/E Ratio
  • ATNM N/A
  • BDL $13.23
  • Revenue Growth
  • ATNM N/A
  • BDL 8.87
  • 52 Week Low
  • ATNM $1.03
  • BDL $23.44
  • 52 Week High
  • ATNM $10.24
  • BDL $29.72
  • Technical
  • Relative Strength Index (RSI)
  • ATNM 43.76
  • BDL 36.80
  • Support Level
  • ATNM $1.18
  • BDL $23.44
  • Resistance Level
  • ATNM $1.34
  • BDL $24.17
  • Average True Range (ATR)
  • ATNM 0.15
  • BDL 0.48
  • MACD
  • ATNM -0.03
  • BDL -0.12
  • Stochastic Oscillator
  • ATNM 11.99
  • BDL 2.91

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About BDL Flanigan's Enterprises Inc.

Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service and Package stores consist of retail liquor sales and related items. The company generates maximum revenue from Restaurant segment.

Share on Social Networks: